Distinct roles of size-defined HDL subpopulations in cardiovascular disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic concepts and literature without a systematic review protocol or meta-analysis.
PubMed 39450930 · doi:10.1097/MOL.0000000000000959
What was done
This narrative review summarizes recent literature evaluating the distinct mechanistic and clinical roles of size-defined high-density lipoprotein (HDL) particle subpopulations (small, medium, and large) in atherosclerotic cardiovascular disease.
What was found
The abstract reports no quantitative values or statistical metrics. It describes mechanistic pathways: small HDL particles promote cellular cholesterol efflux via apolipoprotein A-I engagement with ABCA1, whereas large HDL particles bind scavenger receptor class B type 1 on endothelial cells to restrict LDL entry into the artery wall. The functional role of medium-sized HDL particles remains unclear.
Why it matters
Explains why static HDL-cholesterol (HDL-C) concentrations often fail to reflect cardiovascular risk, supporting a mechanistic shift toward particle size and subfraction function as potential cardioprotective metrics.
Limits
As a narrative review, it lacks a systematic literature search, risk-of-bias assessment, or pooled quantitative effect sizes. The abstract provides no primary human outcome data, sample sizes, or clinical trial endpoints, and the role of the most abundant subpopulation (medium HDL) remains undetermined.
Cited by
- contradicts Small HDL particles are less capable of clearing LDL particles and facilitating reverse cholesterol transport than larger HDL particles.